Nasus Pharma (NSRX) P/S (2025 - 2026)
Nasus Pharma (NSRX) P/S from Dec 31, 2025 to Jul 20, 2026. The TTM Nasus Pharma (NSRX) P/S is 0.02. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Nasus Pharma (NSRX)
| Year | P/S | Change |
|---|---|---|
| 2026 | 0.02 | -67.10% |
| 2025 | 0.07 | N/A |
Comparison Nasus Pharma (NSRX) P/S with competitors
Nasus Pharma (NSRX) P/S is 0.02.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | +2516.88% |
| NVO | Novo Nordisk | 0.66 | +2912.83% |
| GRFS | Grifols SA | 0.67 | +2953.79% |
| AMRN | Amarin Corp | 1.39 | +6226.03% |
| SCLX | Scilex Holding Company | 1.92 | +8615.35% |
| SNY | Sanofi | 2.18 | +9835.05% |
| PFE | Pfizer Inc | 2.18 | +9835.05% |
| BMY | Bristol-Myers Squibb Company | 2.40 | +10818.09% |
| BIIB | Biogen Inc | 2.93 | +13234.72% |
| GSK | GSK Plc | 3.22 | +14572.74% |
| MRK | Merck & Co Inc | 4.54 | +20543.78% |
| AZN | Astrazeneca plc | 4.58 | +20766.79% |
| NVS | Novartis AG | 5.07 | +22974.07% |
| AMGN | AMGEN Inc | 5.15 | +23338.16% |
| GILD | Gilead Sciences Inc | 5.43 | +24612.47% |
| JNJ | Johnson & Johnson | 6.34 | +28753.97% |
| ABBV | Abbvie Inc | 7.15 | +32440.36% |
| LLY | Lilly(Eli) & Company | 14.28 | +64889.69% |